In rabbit platelets, low-dose collagen-induced aggregation depends on synergism between TxA2 and ADP, whereas high-dose collagen induces aggregation via independent release of sufficient TxA2 and ADP.
No takes yet. Share an insight, caveat, or question.
Does not support clinical antiplatelet changes; leaves open TxA2-ADP synergy mechanisms in human platelets.
Lewis et al. (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: